Avalo Therapeutics, Inc. · NASDAQ:AVTX
T. Rowe Price Investment Management, Inc.'s stake in Avalo Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
T. Rowe Price Investment Management, Inc.'s stake in Avalo Therapeutics, Inc. fell below 5%, 3,670 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 3,670
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 0% | 3,670 |
Source
Related
- Avalo Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 15, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026